ImmunoGen Inc (was acquired by AbbVie (NYSE: ABBV) on 12/02/2024) (IMGN) Announces Executive and Board Changes
ImmunoGen Inc (was acquired by AbbVie (NYSE: ABBV) on 12/02/2024) (IMGN) announced changes to its leadership team and board of directors.
The change is effective as of June 15, 2022.
Executive Changes Details:
No specific executive change details provided.
👥 Executive & Board Changes:
Effective Dates: June 15, 2022, April 1, 2022, April 26, 2022
💼 Business Developments:
Partnership: Not available
Acquisition: Not available
Licensing: Not available
Regulatory Approval
Executive Changes
Structured Data:
Company Name: ImmunoGen Inc (was acquired by AbbVie (NYSE: ABBV) on 12/02/2024)
📋 ImmunoGen, Inc. (IMGN) - Executive Changes
Filing Date: 2022-06-17
Accepted: 2022-06-17 17:07:15
Event Type: Executive Changes
Event Details:
👥 Executive & Board Changes:
💼 Business Developments:
Structured Data: